Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells

Author： Yang Qu   Zhang Shanyong   Kang Mingyang   Dong Rongpeng   Zhao Jianwu  

Publisher： Spandidos Publications

E-ISSN： 1791-2431|33|5|2537-2544

ISSN： 1021-335X

Source： Oncology Reports, Vol.33, Iss.5, 2015-05, pp. : 2537-2544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genistein exerts growth inhibition on human osteosarcoma MG-63 cells via PPARγ pathway

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 1131-1140

Spandidos Publications

Access to resources Recommend Favorite

Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells

By                

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1689-1696

Spandidos Publications

Access to resources Recommend Favorite

Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells

By        

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 560-564

Spandidos Publications

Access to resources Recommend Favorite

Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition

By                  

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 540-550

Spandidos Publications

Access to resources Recommend Favorite

Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1177-1184

Spandidos Publications

Access to resources Recommend Favorite